Overview
SLXN market data
Price History
SLXN price chart · 1M
- O
- 0.350300
- H
- 0.360900
- L
- 0.350300
- C
- 0.355600
- Vol
- 1,951.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $0.35
- Previous Close
- $0.35
- Day High
- $0.36
- Day Low
- $0.35
- 52 Week High
- $6.55
- 52 Week Low
- $0.35
- 7 Day Return
- -8.11%
- 30 Day Return
- -85.94%
- 90 Day Return
- -92.85%
- 1 Year Return
- -94.36%
- Daily Notional Volume
- $693.8 Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$89.60 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.27 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.36 – $80.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $489K · P/B 2.31.
Company News
Silexion Therapeutics shares are trading lower after the company reported worse-than-expected Q2 results.Benzinga · Aug 14, 2026, 7:16 PM
Silexion Therapeutics Q2 EPS $(5.17) Misses $(2.12) EstimateBenzinga · Aug 14, 2026, 1:02 PM
Nasdaq Surges 150 Points; US Inflation Rate Slows To 3.4% In JulyBenzinga · Aug 12, 2026, 1:42 PM
Silexion Therapeutics shares are trading lower after the company announced the pricing of its $2.5 million public offering of 3,846,161 shares at $0.65 per share.Benzinga · Aug 12, 2026, 12:39 PM
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 12, 2026, 8:51 AM
Reported Earlier, Silexion Therapeutics Prices $2.5M Public Offering Of 3,846,161 Ordinary Shares At $0.65 Per ShareBenzinga · Aug 12, 2026, 7:24 AM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Aug 11, 2026, 5:06 PM
12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · Aug 7, 2026, 9:05 PM
Silexion Therapeutics shares are trading lower after the company announced additional preclinical findings from its ongoing translational immuno-oncology program evaluating SIL204 in human KRAS-mutant cancer cells.Benzinga · Aug 4, 2026, 5:57 PM
Silexion Therapeutics Announces Preclinical Data Showing SIL204 Upregulated FAS And Downregulated HLA-G Across Three KRAS-Mutant Pancreatic And NSCLC Cell LinesBenzinga · Aug 4, 2026, 1:15 PM